Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.
The American Society of Clinical Oncology (ASCO) held its ASCO Gastrointestinal Cancers Symposium from January 18-20, 2024. During the Symposium, doctors, researchers, scientists, and other stakeholders discussed innovative science and…
Continue Reading
ASCO GI 2024: Oral Antroquinonol Improved Overall Survival Rates in Metastatic Pancreatic Cancer
CureDuchenne, a global leader in research and patient care for Duchenne muscular dystrophy (DMD), has been working to find and fund a cure for DMD for more than two decades.…
Continue Reading
Knowledge is Power: CureDuchenne Cares Educational Events Aim to Equip Families and Caregivers in the Becker and Duchenne Muscular Dystrophy Communities
source: shutterstock.com
For the first six months of his life, Miller Gamberi seemed to be a happy, healthy boy. But his health suddenly shifted; Miller stopped wanting to eat and drink. His…
Continue Reading
Boy with MHC Class II Deficiency Successfully Treated with Bone Marrow Transplant
source: pixabay.com
Type 1 diabetes (T1D), rheumatoid arthritis, lupus, and ulcerative colitis are all examples of autoimmune diseases. An autoimmune disease is a condition that occurs when the immune system mistakenly attacks…
Continue Reading
Study Suggests that Perinatal Depression Risk is Significantly Higher in Women with Autoimmune Diseases
Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…
Continue Reading
Rare Community Profiles: How Matrix Can Be Leveraged to Co-Create and Co-Deliver Care in the Rare Disease Space
source: shutterstock.com
Ring chromosome 14 syndrome is an extremely rare chromosomal disorder that was first described in medical literature in 1971. An estimated 40-80 cases have since been discovered and described. So…
Continue Reading
CharlieFest on March 9: An Event to Raise Ring Chromosome 14 Syndrome Awareness
An estimated one in every four women and one in every nine men is a victim of domestic violence, writes Huecker, King, Jordan, and Smock (2023). This accounts for about…
Continue Reading
USC Alumna Raises Awareness of Relationship Between CTE and Domestic Violence
Genes serve as the intricate orchestrators of our health. By better understanding our genetic makeup, we gain invaluable insights into how our genes shape and affect us. Yet the genetic…
Continue Reading
Naturally Occurring SHLP2 Variant Protects Against Parkinson’s Disease
source: pixabay.com
Chronic spontaneous urticaria (hives) - an itch that can't be scratched. Well, from a literal perspective, you can scratch. But the chronic nature of chronic spontaneous urticaria means that your hives will…
Continue Reading
Phase 1 Clinical Study Initiated to Evaluate EVO756 for Chronic Spontaneous Urticaria
Immunotherapy, targeted therapy, surgery, radiation, chemotherapy, intravesical treatment - oh my! These therapeutic options have all been used to treat individuals living with urothelial carcinoma. But the treatment landscape has…
Continue Reading
FDA Approves Balversa (Erdafitinib) for Locally Advanced or Metastatic Urothelial Carcinoma
Source: Pixabay.com
Editor's Note: Chronic conditions and rare diseases don't discriminate, Patient Worthy and its partners are interested in amplifying the voices of those from all identities and backgrounds. If you have…
Continue Reading
Could Low Serotonin Cause MCI and Alzheimer’s Disease?
source: pixabay.com
Editor's Note: Chronic conditions and rare diseases don't discriminate, Patient Worthy and its partners are interested in amplifying the voices of those from all identities and backgrounds. If you have…
Continue Reading
FLORetina-ICOOR Meeting: Do GLP-1 Agonists Increase Risk of Diabetic Retinopathy?
source: shutterstock.com
In December 2023, clinical-stage biopharmaceutical company Savara Inc. announced that the company had launched a serum-based blood test to aid in diagnosing autoimmune pulmonary alveolar proteinosis (aPAP). While aPAP is…
Continue Reading
aPAP ClearPath Blood Test Helps Physicians Diagnose Autoimmune Pulmonary Alveolar Proteinosis
source: shutterstock.com
Genes hold the key to our health. Through revolutionary gene therapy solutions, the medical field is transforming to laud the power and precision of personalized medicine. Gene therapy has the…
Continue Reading
UMass Chan Progressing on Gene Therapy Vector for Cockayne Syndrome
Photo courtesy of Greg Hadley and Uplifting Athletes
In the hallowed halls of Colgate University, a young man named Greg Hadley found his calling in an unexpected place: the field of rare diseases. Little did he know that…
Continue Reading
Friends in the Fight: Athlete’s Loss Inspires Support for Tay-Sachs Research via Uplifting Athletes’ Young Investigator Draft
Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…
Continue Reading
Rare Community Profiles: Peggy Lillis’ Legacy: How the End of an Extraordinary Life Launched a Foundation for C. Diff Education, Awareness, and Policy
source: shutterstock.com
In December 2023, pharmaceutical and biotechnology company Moderna announced that results from a Phase 2/3 clinical trial were published in The New England Journal of Medicine. The study explored an mRNA-based…
Continue Reading
ICYMI: Phase 3 Results on mRNA-1345 for RSV Published in NEJM
For the first six months of his life, Oliver Mills seemed to be developing fairly normally. He was a happy, bubbly baby. His mother Laurel found joy in every smile,…
Continue Reading
Oliver’s Story: What It’s Like to Live with Beta-Mannosidosis
source: shutterstock.com
Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…
Continue Reading
Rare Community Profiles: A Conversation with Rallybio CEO Stephen Uden on the Need for Rare Disease Drug Development
Source: pixabay.com
Omega-3 fatty acids like alpha-linlenic acid or docosahexaenoic acid are "healthy fats" that are found in foods like flaxseed, fish, soybeans, and canola oil; they may also be given via…
Continue Reading
Could Omega-3 Fatty Acids Slow Pulmonary Fibrosis Progression?
source: shutterstock.com
In December 2023, clinical-stage biopharmaceutical company Clene Nanomedicine ("Clene") shared that it had met with the U.S. Food and Drug Administration (FDA) regarding Accelerated Approval for CNM-Au8®, an experimental therapy…
Continue Reading
No Accelerated Approval for Experimental ALS Drug CNM-Au8
The research landscape for Duchenne muscular dystrophy (DMD) has been steadily increasing. Researchers are exploring more therapies, including gene therapies, that could transform the lives of those with this rare…
Continue Reading
SGT-003 Granted Orphan Drug Designation for Duchenne Muscular Dystrophy (DMD)
source: shutterstock.com
In 2015, the U.S. Food and Drug Administration (FDA) approved NUCALA (mepolizumab) for the treatment of severe eosinophilic asthma in adolescents and adults ages 12 and older, and by 2022,…
Continue Reading
NUCALA Now Approved in China for Severe Eosinophilic Asthma
source: shutterstock.com
In mid-January 2023, Kristi Rosa of OncLive reported that the European Medicines Agency (EMA) granted Orphan Drug designation to pimicotinib (ABSK021) for inoperable tenosynovial giant cell tumors (TGCT). Orphan Drug…
Continue Reading
Pimicotinib Earns Orphan Drug Designation from the EMA for Tenosynovial Giant Cell Tumors
Photo by Robina Weermeijer on Unsplash
Do you have cystic fibrosis? Are you searching for a stronger sense of community? Then BreatheCon, the unique virtual event spearheaded by the Cystic Fibrosis Foundation, is perfect for you! …
Continue Reading
Cystic Fibrosis Foundation to Host 8th Annual BreatheCon on February 9-10, 2024